Candel’s pivotal phase 3 clinical trial in prostate cancer was conducted under a SPA agreed with the FDA. The FDA has also granted Orphan Drug Designation to CAN-2409 for the treatment of PDAC.

Brensocatib is an oral, selective, competitive, and reversible inhibitor of DPP-1. 19 In the phase 2 WILLOW trial involving adults with bronchiectasis, treatment with a 10-mg or 25-mg dose of ...

4D Molecular Therapeutics has initiated its first Phase 3 trial for 4D-150 in wet AMD and expanded its clinical pipeline. Quiver AI Summary. 4D Molecular Therapeutics (4DMT) has announced ...

A second phase 3 pivotal clinical trial investigating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia met its primary and key secondary endpoints, according to a press ...

Adial’s Phase 3 trial for AD04 will target genotype-specific subgroups of heavy drinkers with Alcohol Use Disorder. The trial is expected to launch in late 2025, with interim analyses ...

Phase 3 HIV Treatment Switch Studies: Key Findings From Recent Clinical Trials. Author(s): Sharon Walmsley, CM, MD, FRCPC .

About Moleculin Biotech, Inc. Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical company advancing a pipeline of therapeutic candidates addressing hard-to-treat tumors and viruses.

Methods Trial Design We conducted this ongoing phase 3, multicenter, randomized, double-blind, placebo-controlled outcome trial at 253 clinical sites in 37 countries.

The Phase 3 AFFIRM-AL clinical trial was a global, double-blind, placebo-controlled, time-to-event clinical trial that enrolled 207 newly diagnosed, treatment naïve patients with Mayo Stage IV AL ...

Professor of neurology at UCLA and a co-principal investigator, Dr. Steven Cramer, MD affirms, “Reaching Phase 3 in a clinical trial of this scale is a hard-won milestone that has been twelve ...